In the field of colorectal cancer (CRC) treatment, diagnostic modalities and chemotherapy regimens have progressed remarkably in the last two decades. However, it is still difficult to identify minimal residual disease (MRD) necessary for early detection of recurrence/relapse of tumors and to select and provide appropriate drugs timely before a tumor becomes multi-drug-resistant and more aggressive. We consider the leveraging of in-depth genomic profiles of tumors as a significant breakthrough to further improve the overall prognosis of CRC patients. With the recent technological advances in methodologies and bioinformatics, the genomic profiles can be analyzed profoundly without delay by blood-based tests—‘liquid biopsies’. From a clinical...
Precision medicine, a concept that has recently emerged and has been widely discussed, emphasizes ta...
Despite many advances in the diagnosis and treatment of colorectal cancer (CRC), its incidence and m...
Colorectal cancer (CRC) has been ranked as the third most prevalent cancer worldwide. Indeed, it rep...
Drug-specific therapeutic approaches for colorectal cancer (CRC) have contributed to significant imp...
Background. Colorectal cancers (CRC) shed DNA into blood circulation. There is growing evidence that...
Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide. It is a heterogeneous...
(1) Background: Resistance mechanisms represent a barrier to anti-cancer therapies. Liquid biopsies ...
The term liquid biopsy refers to the analysis of biomarkers in any body fluid, including blood, urin...
Colorectal cancer (CRC) is one of the most common gastrointestinal tumors and the second leading cau...
The treatment of metastatic colorectal cancer (mCRC) has improved since the introduction of the epit...
The introduction of immunotherapy has revolutionized the oncological targeted therapy paradigm. Micr...
Background: Liquid biopsy is considered a repeatable, non-invasive and dynamic tool. It could be abl...
International audienceColorectal cancer is a major health burden with a prognosis that has been impr...
Colorectal cancer is one of the most frequent solid malignancies worldwide. The treatment is either ...
Liquid biopsy has been proposed to be a promising noninvasive tool to obtain information on tumor pr...
Precision medicine, a concept that has recently emerged and has been widely discussed, emphasizes ta...
Despite many advances in the diagnosis and treatment of colorectal cancer (CRC), its incidence and m...
Colorectal cancer (CRC) has been ranked as the third most prevalent cancer worldwide. Indeed, it rep...
Drug-specific therapeutic approaches for colorectal cancer (CRC) have contributed to significant imp...
Background. Colorectal cancers (CRC) shed DNA into blood circulation. There is growing evidence that...
Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide. It is a heterogeneous...
(1) Background: Resistance mechanisms represent a barrier to anti-cancer therapies. Liquid biopsies ...
The term liquid biopsy refers to the analysis of biomarkers in any body fluid, including blood, urin...
Colorectal cancer (CRC) is one of the most common gastrointestinal tumors and the second leading cau...
The treatment of metastatic colorectal cancer (mCRC) has improved since the introduction of the epit...
The introduction of immunotherapy has revolutionized the oncological targeted therapy paradigm. Micr...
Background: Liquid biopsy is considered a repeatable, non-invasive and dynamic tool. It could be abl...
International audienceColorectal cancer is a major health burden with a prognosis that has been impr...
Colorectal cancer is one of the most frequent solid malignancies worldwide. The treatment is either ...
Liquid biopsy has been proposed to be a promising noninvasive tool to obtain information on tumor pr...
Precision medicine, a concept that has recently emerged and has been widely discussed, emphasizes ta...
Despite many advances in the diagnosis and treatment of colorectal cancer (CRC), its incidence and m...
Colorectal cancer (CRC) has been ranked as the third most prevalent cancer worldwide. Indeed, it rep...